science

Closing gaps in HS care through community engagement and scientific innovation

Borysiuk Viktor (External) — Wed, 20 Nov 2024 10:25:57 +0000

Closing gaps in HS care through community engagement and scientific innovation

Rhonda Peebles, Dermatology US

Borysiuk Vikto… Wed 20/11/2024 - 11:25

This past summer, ��ֳ� welcomed members of the hidradenitis suppurativa (HS) community – dozens of people living with HS, caregivers, advocacy groups, and medical experts – onto our Atlanta campus for our HS Summit to advance understanding of the treatment journey and unmet needs of those impacted by this disease.

It was incredibly powerful to hear patient testimony firsthand throughout the weekend. I was struck by the openness and honesty of the community as they shared their physical and emotional struggles and the importance of speaking up. Engaging with the HS community and witnessing their strength and perseverance is one of the most rewarding and inspiring parts of my job at ��ֳ�.

Hearing insights and experiences from the HS community have encouraged our drive to bring a new treatment option to people living with this painful, chronic inflammatory skin condition. Today, I’m excited and proud that dermatologists have more options than ever to effectively manage HS.

Our efforts to support both patients and clinicians are ongoing and go far beyond treatment. One big initiative is supporting a registry of HS patients in partnership with the University of California San Francisco (UCSF), which will facilitate research of this disease through collaboration between investigators, clinicians, patients, and industry to improve the lives of people living with HS. We are also proud to sponsor the HS Papaya app, which was developed by two leading HS physicians to help people living with HS track their symptoms and communicate those to their provider, connect with an HS center of excellence, and more. And at the recent Symposium on Hidradenitis Suppurativa Advances (SHSA) conference, we shared new HS data and met with key third party medical and patient advocacy organizations to advance our collaborative initiatives. These are just a few of the things we’re doing as we aim to establish leadership in HS and dermatology.

As advocacy leader Brindley Brooks, co-founder and president of HS Connect, said at the HS Summit, “There’s never a good time to have HS, but there’s never been a better time to have HS.” I am inspired each day as I work alongside those with such a dedication to improving the lives of people impacted by HS. It is a hopeful time. As we forge forward, I know that there will continue to be more treatment options, awareness, and support resources for HS patients – and I am honored to be part of this new era for HS care.

about ucb

HS dermatology science

111 Likes

World Arthritis Day 2024: Informed Choices, Better Outcomes

Andrea_Puletto — Fri, 11 Oct 2024 09:33:47 +0000

World Arthritis Day 2024: Informed Choices, Better Outcomes

Marie Teil, Special Patient Populations

Andrea_Puletto Fri 11/10/2024 - 11:33

On October 12, World Arthritis Day will raise awareness about the realities of living with rheumatic and musculoskeletal diseases (RMDs) and to advocate for better research, education, and patient support. On this day, we are all reminded of our collective responsibility to empower those affected by RMDs – including women and their families who lack concrete data and clear guidance about disease management and treatment, particularly during pregnancy and breastfeeding.

This year’s theme – “Informed Choices, Better Outcomes” – underscores how important it is for people living with RMDs to make informed, evidence-based decisions in partnership with their healthcare teams. Despite the notion that there is an overwhelming amount of information for people with RMDs to access, this is simply not the case for women in their childbearing years who seek robust and relevant data.

So much of my role at ��ֳ� as the Global Head of Women of Childbearing Age has centered around the idea that women need to be protected through research, not from research. We cannot allow women with chronic diseases to be continuously overlooked in clinical research due to perceived liability and risk. Although progress has been made in this space, additional work is needed to create a more balanced view in clinical research.

Supporting World Arthritis Day 2024 and uniting with a global community dedicated to bringing evidence and research to patients is a step in the right direction. There is great power in collaboration, and it begins with facing the challenge head-on and recognizing that there is more work to be done to help improve patient outcomes.

Join us in raising awareness by sharing this post and supporting research initiatives. Together, we can support those living with RMDs and strive for a future where everyone can live their lives to the fullest without fear or uncertainty of how certain disease management decisions will impact them or their families. Thank you for joining us in this important cause.

Follow me, @MarieTeil, on LinkedIn as well as ��ֳ�’s social channels for more updates.

about ucb

arthritis Immunology science World Arthritis Day rheumatic and musculoskeletal diseases RMDs

168 Likes

ASBMR Annual Meeting 2024 overview: prioritizing patient-centered care

Andrea_Puletto — Thu, 26 Sep 2024 12:26:46 +0000

ASBMR Annual Meeting 2024 overview: prioritizing patient-centered care

Snauwaert Adriaan, Immunology Global Communication

Andrea_Puletto Thu 26/09/2024 - 14:26

The American Society for Bone and Mineral Research (ASBMR) Annual Meeting is the largest and most comprehensive global congress dedicated to bone, mineral, and musculoskeletal health. Each year, thousands of leading experts, researchers, and clinicians from around the world gather to exchange knowledge and present the latest breakthroughs in disease management, treatment strategies, and scientific innovation. The 2024 meeting promises to continue this tradition of excellence, offering a unique platform for collaboration and discovery in the ever-evolving field of bone health.

This year, ��ֳ� and Amgen will unveil crucial new data that demonstrate significant advancements in reducing fracture risk and improving bone strength, particularly for patients at high risk of osteoporosis-related fractures. These findings will emphasize the value of new therapeutic approaches in comparison to existing treatments, highlighting their potential to transform osteoporosis care and improve long-term outcomes for patients.

At ��ֳ�, we remain dedicated to advancing research and ensuring patients have access to transformative treatments for osteoporosis. Earlier this year, we caught up with experts to discuss the urgent need to address bone health in aging populations and innovation in osteoporosis treatments. These conversations continue at ASBMR 2024, where we look forward to sharing groundbreaking data and collaborating with the global community to drive progress in bone disease management. Watch the video below!

Complementing this is our Fragility Fracture in Focus podcast series which explores how the P4 Health Spectrum (predictive, preventive, personalized, and participatory) – an increasingly recognized cornerstone of proactive modern medicine – looks to shift focus away from disease to the promotion of a state of wellness. Listen NOW to the Fragility Fractures in Focus podcast to find out more! (For healthcare professionals only).

Stay connected for updates throughout the congress, as we continue to push the boundaries of bone health research and patient care.

about ucb

innovation Immunology science

136 Likes

Building trust: The crucial bridge between AI and healthcare

Chiara Vona — Fri, 15 Dec 2023 08:58:16 +0000

Building trust: The crucial bridge between AI and healthcare

Colin Lake, Digital Care Transformation Neurology

Chiara Vona Fri 15/12/2023 - 09:58

For three decades, we’ve been committed to people living with epilepsy and their families, surrounding the patient and caregiver through every step of their care journey. In the ever-evolving healthcare landscape, Artificial Intelligence (AI) and the digitalization of healthcare, is set to create new standards and advancements in care for people living with epilepsy and rare epileptic syndromes. This digitalization is revolutionizing the way we understand and approach these complex neurological disorders, with AI helping us to push the boundaries of healthcare and drug development by enabling us to support more precise diagnoses, detect patterns and trends, and aid disease prevention.

However, the successful integration of AI into healthcare relies heavily on a foundation of trust – trust from the public, medical professionals, and caregivers. We understand that this trust has improved drastically over the past few years, with events like COVID-19 necessitating remote digital healthcare, but there remains a distrust in the public domain. The main questions we are being asked are “Where is my data being used?”, “Who is looking at my data?” and “How will my data be used?”

Because of this, it is our role as experts in neurology to address these questions and be transparent. While the challenge of trust is not specific to ��ֳ� but industry-wide, we are continuously working to build that trust with patients, caregivers, and medical professionals.
Collaboration and partnerships are an essential way to build trust, and we know that we cannot do this alone. We must turn to expert digital partners, such as Microsoft, to support us on this journey. The continuous work we do together establishes a strong foundation for the future and landscape of neurology.

One example of how we’re using AI is the development of wearable technology – being able to track movement disorders not only helps patients but also increases our own understanding of how they manage their condition. The development of this technology also allows us to monitor patient data in real-time but has also enabled us to engage with a larger, more diverse patient pool within remote clinical trials. We can collect more data and ensure we secure better equity around patients, effectively reaching underserved populations.

Another area we are currently exploring is the use of ‘Digital Twins’ - a digital copy - to accurately reflect a physical human brain. The use of this modeling technology could assist in identifying the pattern of symptomatic behaviors such as seizures and, in principle, help medical professionals to individualize treatment based on the simulated behavior to predict how a specific patient might react to treatment.

Given the digital landscape is evolving rapidly, we must keep up with the pace and constantly look at ways we can digitalize our offering to secure a better outcome for our patients. It has never been more important to provide the best outcome for a patient across their entire journey and digital technology can help us achieve that.

innovation

science Patients Artificial Intelligence

668 Likes

We are ��ֳ� and we are driven by science

Chiara Vona — Wed, 13 Dec 2023 12:45:49 +0000

We are ��ֳ� and we are driven by science

Scott Fleming, Global Communications & Company Reputation

Chiara Vona Wed 13/12/2023 - 13:45

At ��ֳ� we are ‘driven by science’, it’s a key aspect of our culture. Being driven by science signifies a commitment to making decisions and taking actions based on evidence, research, and empirical data. It means adopting novel technologies, exploring new modalities, and embracing the quest for knowledge, understanding, and truth that is at the heart of scientific endeavor.

Dynamic and Agile Innovator

We understand that knowledge isn't static - it evolves and it grows. So, we work hard to harness the power of knowledge, adapt to changing circumstances, seize opportunities, and drive healthcare innovation. ��ֳ�’s belief is that we can do this because we see potential where others see challenges. We see opportunities where others see obstacles. And most importantly, we see a future full of possibilities. This is what makes us, us. We aren’t content with merely keeping pace with industry trends. We anticipate them. We shape them. Through a potent combination of being dynamic and agile.

Harnessing Technology to Drive Health Innovation

At ��ֳ�, we believe in the transformative power of technology. We see it as a catalyst for change, a tool for progress, and an avenue for discovery. Our commitment to leveraging technology in our discovery and development pursuits is unwavering, and it's this dedication that helps fuels our drive for healthcare innovation. Today, advancements in fields like artificial intelligence, machine learning, big data, computer aided drug discovery and genomics are advancing the way we approach drug discovery and development. We are excited about the possibilities that technology brings to the field of science. As we continue to harness its power, we remain committed to our mission of improving lives through purpose-driven, inclusive, and dynamic health solutions.

Drug Modality Platforms: A New Era of Precision Medicine

While technology provides us with the tools to innovate, it’s the emergence of new and advancement of current drug modality platforms that's truly propelling us into a new era of drug discovery. These modalities, which range from small molecules and proteins to antibodies, cell therapies, and gene therapy, offer unprecedented opportunities to look at designing targeted therapies. The promise that this ‘precision’ medicine approach is not just innovative but transformative.

Driven by Science

But most importantly, being driven by science is about quickly adapting to our changing environment, using new technologies and drug modalities, and capitalizing on knowledge gains and our greater understanding of human disease biology to create positive change. It's about leveraging scientific insights to improve patients’ lives, build a better, more sustainable future, and make a meaningful difference in the world.

You can learn more about what shapes our purpose, drives our actions, and defines our culture by visiting Innovation is |��ֳ�

innovation

science Our Science innovation technology

444 Likes

A Culture of Patient-Centered Healthcare Innovation

Chiara Vona — Mon, 27 Nov 2023 10:39:19 +0000

A Culture of Patient-Centered Healthcare Innovation

Scott Fleming, Global Communications & Company Reputation

Chiara Vona Mon 27/11/2023 - 11:39

In a world where scientific innovation is advancing at an unprecedented pace, it's easy to get caught up in the excitement of cutting-edge technology. However, at ��ֳ�, we think technology is only part of the innovation puzzle. ��ֳ�'s ethos is deeply rooted in the belief that innovation should revolve around the patients we serve, and we have a culture where the patient is not just the end-user, but the beginning and the centerpiece of every breakthrough. Patient-centricity is at the heart of everything we do.

Greater Knowledge and Deeper Understanding

At ��ֳ� we ensure that each stage of the discovery and development journey is dedicated to comprehending the unique challenges faced by patients, and subsequently, providing solutions that enhance their quality of life. How? By being data-driven and question-led. By seeking a deep understanding of a disease and its underlying pathobiology. By exploring new pathways and approaches and being unafraid to take risks and challenging the status quo.

Unlocking Disease Drivers Fuels Innovation

A better understanding of a disease, its drivers and its pathobiology greatly enhances drug discovery by providing critical insights into the underlying molecular and biological factors responsible for diseases. By unravelling these intricacies, it can enable our scientists to identify specific drug targets, personalizes treatment options, and fosters biomarker discovery for diagnostics and clinical trials. Mechanism-based therapies become possible with the goal of reducing side effects and off-target impacts.
In essence, by exploring the intricate details of diseases and their pathobiology, we're not just uncovering valuable insights. We're fueling a wave of innovation in patient-centered healthcare that promises to advance patient care and public health.

Human Centric Health

At ��ֳ�, there’s one form of partnership that we’ve found to be more transformative than any other and that’s the partnership with patients. To help bring innovation to our research, we work hard to build a trusted partnership with patients. We take the time to listen and learn from patients as this provides us with insights on the personal impact of their condition. Insights that don’t come from trial data or the test tube. In fact, when you work at ��ֳ� you quickly understand that patients are not only patients but are first and foremost human beings.
It’s an empowering way to work and it sees us prioritize the individual needs, preferences, and experiences of patients. Take for example our clinical trials where many of the patients that we serve have complex conditions and our aim is to make clinical trial participation as easy as possible, enabling participants to continue with their day-to-day lives with minimal disruption. By combining patient-centered design with innovative technologies, we seek to increase flexibility and optionality.

A Home for Patient-Centered Innovation

We’ve moved away from seeing patients as just patients. By really listening and engaging with them as partners, from early research through to late-stage development, we can truly innovate, improve the patient reality and drive patient-centered healthcare.
To learn more about our culture and how innovation drives everything we do visit Innovation is | ��ֳ�.

innovation

innovation science patients

400 Likes

Encouraging Innovation: ��ֳ�'s Culture of Connection and Collaboration

Chiara Vona — Thu, 02 Nov 2023 12:22:26 +0000

Encouraging Innovation: ��ֳ�'s Culture of Connection and Collaboration

Scott Fleming, Global Communications & Company Reputation

Chiara Vona Thu 02/11/2023 - 13:22

At ��ֳ�, we don’t just want to keep up with innovation, but lead the way. And that means creating the right culture for innovation to thrive, and we believe that it starts with forging strong connections, nurturing collaborations, and encouraging interdisciplinary teamwork. By embracing these principles, we aim to make groundbreaking discoveries that, we hope, can dramatically improve healthcare for patients worldwide.

A Place Where Ideas Can Soar

Welcome to a home without boundaries, to a place where individuals, communities and companies can connect. We work hard to create an environment that supports connection, collaboration, and co-creation. We do this because we know the ability to align great minds and different skills together around a particular topic or task can lead to creative and innovative solutions.

The Power of Connections

Building a culture of connection and collaboration requires time, investment, and effort, but the rewards are far-reaching. By fostering strong collaborations within our teams and partnering with external experts, we're tapping into a collective intelligence that can enrich our thinking and propel us forward. Our commitment to ‘being connected’ is one driving force behind our pace of innovation.

Agile Networks for Openness

Innovation requires agility, and that's exactly what our culture is built on. From our research scientists to our clinical trial associates, we value agility, openness, and flexibility. Our have a culture where ideas can be shared openly, knowledge can be transferred quickly, and novel concepts can be explored fearlessly. This culture of openness breaks down silos and empowers every member of the ��ֳ� team to contribute their unique insights, sparking innovative ideas from unexpected sources.

Where Science Meets Solutions

We understand that innovation is a multi-disciplinary process. That's why we bring together our scientists, and experts from different fields to tackle complex challenges. By embracing diverse perspectives, we aim to enrich our thinking and find holistic solutions that aim to have a real impact on patient lives and advance medical science.

You can learn more about ��ֳ�'s commitment to innovation through connectivity and our drive to create a home without boundaries by visiting our innovation is webpage.

innovation

science innovation culture collaboration

500 Likes

��ֳ� Innovation in Business, Technology and Science

Chiara Vona — Thu, 19 Oct 2023 14:20:08 +0000

��ֳ� Innovation in Business, Technology and Science

Kishan Vaghela, Business Operations Excellence

Chiara Vona Thu 19/10/2023 - 16:20

Innovation is a well-used word in the pharmaceutical industry. It has been used to describe culture, adopting new capabilities or methods, or bringing ideas from other industries into ours. Essentially, innovation does not have a one size fits all definition, but I think we can all agree it’s a critical element of progress and growth in today's rapidly evolving world.

Creating New Opportunities for Growth and Progress

The world is constantly changing, and with that comes new challenges, problems, and opportunities. Innovation allows us to adapt to these changes, and to create solutions that can make a positive impact on society. When we innovate, we are not just solving problems, but we are also creating new opportunities for growth and progress.

Innovation is not just about coming up with new ideas. It is about turning those ideas into practical solutions that have operational and customer value. This means that we should not only focus on creating something new but also on incrementally improving existing solutions to provide a tangible value to patients’ lives.

Culture of Curiosity and Innovation

To stay competitive in today's fast-paced and ever-changing market we must continue to push innovation in science. Therefore, at ��ֳ� we encourage and foster a culture of curiosity and innovation. We do this by weaving creativity and collaboration into the fabric of everything we do.

Innovation is a critical aspect of progress and growth. It allows us to adapt to change, solve problems, and create new opportunities. It is essential to foster a culture of and encourage creative thinking to make a positive impact and bring value to patients’ lives.

Find out more about innovation at ��ֳ� here.

innovation

science Patients innovation

485 Likes

Transformative Partnerships: ��ֳ�'s Patient-Centric Approach to Advancing Healthcare

Chiara Vona — Wed, 27 Sep 2023 08:52:46 +0000

Transformative Partnerships: ��ֳ�'s Patient-Centric Approach to Advancing Healthcare

Mitch Herndon, Clinical study patient engagement

Chiara Vona Wed 27/09/2023 - 10:52

We hear a lot in the pharmaceutical industry about collaborations and partnerships that are formed to drive innovation and breakthroughs. Big name partnerships are never far from the front pages, but successful partnerships come in all shapes and sizes.

At ��ֳ�, there’s one form of partnership that we’ve found to be more transformative than any other and that’s the partnership with patients. To help bring innovation to our science, we work hard to build a trusted partnership with patients. We take the time to listen and learn from patients as this provides us with insights on the personal impact of their condition. Insights that don’t come from trial data or the test tube.

Patient-Centered Insights: The Art of Listening

The art of listening goes beyond just hearing words; it involves active engagement with the speaker. True listening grants us a deeper understanding and appreciation of others' perspectives and emotions. Through empathetic listening, we can better support and show compassion.

Each person holds a unique experience and knowledge, and by attentively listening, we gain valuable insights that enrich our own understanding. The act of genuine listening allows us to learn from other’s successes, failures, and diverse experiences, expanding our knowledge beyond what we could achieve individually.

Cultivating Patient-Centricity: ��ֳ�'s Purpose-Driven Research and Development

It’s an empowering way to work. Often, in research and development, where innovations are sometimes decades in the making, you can feel extracted from the focus of your research efforts. For us, the constant feedback loop from patients allows innovation in science to thrive. It’s why we come to work: to listen, to learn, and to make a real difference to the lives of patients suffering from severe diseases, every day.

To learn more about how innovation drives everything we do visit Innovation is | ��ֳ�

innovation

Patients innovation science R&D

Comment:

Posted by canadian pharm…, 24 October 2023

This page definitely has all the information I needed about this subject and didn't know who to ask.

415 Likes

��ֳ� partnership with the Royal Society of Chemistry showcased at Annual Conference

Chiara Vona — Mon, 24 Jul 2023 13:23:20 +0000

��ֳ� partnership with the Royal Society of Chemistry showcased at Annual Conference

Nicole Yost, Global Communications

Chiara Vona Mon 24/07/2023 - 15:23

Over the past 10 years ��ֳ� has been accredited by the Royal Society of Chemistry to oversee a 2-year training program whereby Chartered Chemist (CChem) status is awarded to the applicant. This process involves the applicant, or mentee, working with a ��ֳ� mentor who has previously achieved CChem status, to fulfil 14 attributes defined by the RSC.

The CChem status demonstrates a commitment to the continued advancement of the chemical sciences and their learning and continued professional development as whole.

Meet one of our current mentees, Justin Staniforth.

Earlier this month, Justin was invited to give a short talk at the Annual RSC CChem Conference.

In doing so Justin covered the topic of ethical practice in his ��ֳ� role and discussed how he goes about creating an open and engaging atmosphere to encourage his colleagues to act in an ethical fashion. Justin showcased his career journey at ��ֳ� so far and finished by reflecting on how ethical behaviors are demonstrated in the CChem attributes.

This was followed by breakout sessions and robust discussion with conference attendees. The talk was well-received and greatly appreciated by the RSC, with the event contributing as evidence for Justin’s ongoing portfolio to achieve CChem status.

“The best thing about the CChem program is being recognized for what you do on a daily basis”, Justin commented. “Being a mentee is a valuable way to step back and review what you do and how you can do it better and make more positive contributions to both the department and the company as a whole”.

“We are proud of our CChem Program,” says James Frost, ��ֳ� Principal Scientist, Medicinal Chemistry, and Co-ordinator of the initiative. “We are re-accredited every five years by the Society and we make efforts to bring in mentees from different backgrounds who can then pass on their learnings.”

“As part of our outreach program, I am keen to get the younger generations involved. Most of the mentees go on to become mentors themselves,” he added.

The 14 attributes of the 2-year program defined by RSC span 5 key areas:

Demonstrate and develop your knowledge of the chemical sciences
Professionalism
Communication and Influencing Skills
Professional Responsibilities
Supporting the Profession

Fulfilment of the 14 attributes is demonstrated by the applicant by collecting a portfolio of evidence over the 2-year mentoring period, followed by a final examination by the RSC and an external examiner.

Justin concludes: “I would encourage anybody considering applying to undertake the CChem accreditation scheme, not to hesitate and sign up! It has helped me focus on adding value to what I do on a daily basis, by stopping to think about how I can do things differently to make more of a positive contribution”.

about ucb

partnerships chemistry science

411 Likes

science

Closing gaps in HS care through community engagement and scientific innovation

Leave a Comment

World Arthritis Day 2024: Informed Choices, Better Outcomes

Leave a Comment

ASBMR Annual Meeting 2024 overview: prioritizing patient-centered care

Leave a Comment

Building trust: The crucial bridge between AI and healthcare

Leave a Comment

We are ��ֳ� and we are driven by science

Dynamic and Agile Innovator

Harnessing Technology to Drive Health Innovation

Drug Modality Platforms: A New Era of Precision Medicine

Driven by Science

Leave a Comment

A Culture of Patient-Centered Healthcare Innovation

Greater Knowledge and Deeper Understanding

Unlocking Disease Drivers Fuels Innovation

Human Centric Health

A Home for Patient-Centered Innovation

Leave a Comment

Encouraging Innovation: ��ֳ�'s Culture of Connection and Collaboration

Leave a Comment

��ֳ� Innovation in Business, Technology and Science

Creating New Opportunities for Growth and Progress

Culture of Curiosity and Innovation

Leave a Comment

Transformative Partnerships: ��ֳ�'s Patient-Centric Approach to Advancing Healthcare

Patient-Centered Insights: The Art of Listening

Cultivating Patient-Centricity: ��ֳ�'s Purpose-Driven Research and Development

Leave a Comment

��ֳ� partnership with the Royal Society of Chemistry showcased at Annual Conference

Leave a Comment

science

Closing gaps in HS care through community engagement and scientific innovation

Leave a Comment

World Arthritis Day 2024: Informed Choices, Better Outcomes

Leave a Comment

ASBMR Annual Meeting 2024 overview: prioritizing patient-centered care

Leave a Comment

Building trust: The crucial bridge between AI and healthcare

Leave a Comment

We are ������ֳ� and we are driven by science

Dynamic and Agile Innovator

Harnessing Technology to Drive Health Innovation

Drug Modality Platforms: A New Era of Precision Medicine

Driven by Science

Leave a Comment

A Culture of Patient-Centered Healthcare Innovation

Greater Knowledge and Deeper Understanding

Unlocking Disease Drivers Fuels Innovation

Human Centric Health

A Home for Patient-Centered Innovation

Leave a Comment

Encouraging Innovation: ������ֳ�'s Culture of Connection and Collaboration

Leave a Comment

������ֳ� Innovation in Business, Technology and Science

Creating New Opportunities for Growth and Progress

Culture of Curiosity and Innovation

Leave a Comment

Transformative Partnerships: ������ֳ�'s Patient-Centric Approach to Advancing Healthcare

Patient-Centered Insights: The Art of Listening

Cultivating Patient-Centricity: ������ֳ�'s Purpose-Driven Research and Development

Leave a Comment

������ֳ� partnership with the Royal Society of Chemistry showcased at Annual Conference

Leave a Comment

We are ��ֳ� and we are driven by science

Encouraging Innovation: ��ֳ�'s Culture of Connection and Collaboration

��ֳ� Innovation in Business, Technology and Science

Transformative Partnerships: ��ֳ�'s Patient-Centric Approach to Advancing Healthcare

Cultivating Patient-Centricity: ��ֳ�'s Purpose-Driven Research and Development

��ֳ� partnership with the Royal Society of Chemistry showcased at Annual Conference